Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

2.

"We Caught It Early": Advantage or Disadvantage?

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

A protein with new anticancer activity has been identified

5.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot